Non response at week 4 as clinically useful indicator for antidepressant combination in major depressive disorder. A sequential RCT - Kato M, Takekita Y, Koshikawa Y, Sakai S, Bandou H, Nishida K, Sunada N, Onohara A, Hatashita Y, Serretti A, Kinoshita T.

We aimed to compare the efficacy and tolerability of mirtazapine versus SSRIs and to assess whether "non-response at week 4" may be a clinical indicator for combining mirtazapine and SSRIs for subsequent treatment. One-hundred fifty-four outpatients with M...
Source: SafetyLit - Category: Global & Universal Tags: Program and Other Evaluations, Effectiveness Studies Source Type: news